XM non fornisce servizi ai residenti degli Stati Uniti d'America.

XM non fornisce servizi ai residenti degli Stati Uniti d'America.
A
A

Agilent

News

Reuters - 2 settimane fa

Italy - Factors to watch on October 24

Italy - Factors to watch on October 24 The following factors could affect Italian markets on Thursday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy. New items are marked with (*). For a complete list of diary events in Italy please click on IT/DIA . DEBT Treasury announces sale of 6-month BOT bills, with relative amounts to be auctioned on Oct.
A
C
E
E
I
S
U
I
T
I
U
Reuters - 3 settimane fa

S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT S&P 500 .SPX Top Performers Percent Change United Airlines Holdings Inc UAL.OQ +13.9% Delta Air Lines Inc DAL.N +6.9% Morgan Stanley MS.N +6.7% Walgreens Boots Alliance Inc WBA.OQ +5.8% Synchrony Financial SYF.N +5.7% Bottom Performers Percent Change Mettler-Toledo Internationa
A
W
U
U
M
S
Reuters - 3 settimane fa

Bernstein expects a 'not so scary' Q3 for US life sciences firms

BUZZ-Bernstein expects a 'not so scary' Q3 for US life sciences firms ** Brokerage Bernstein expects a "not so scary" Q3 earnings season for U.S. life sciences and tools firms, which "would be a real treat" for investors ** "With the recovery timeline for life science tools continuing to push out (further), some investors feel like they have been t
A
I
T
W
Reuters - 4 settimane fa

Low-cost hybrid tech gives Renault breathing space in tough EV transition

FOCUS-Low-cost hybrid tech gives Renault breathing space in tough EV transition Renault's hybrid sales rise 55% in January-August French carmaker's low-cost hybrid tech uses fewer parts Renault's EV sales stagnant, needs 20% EV sales to meet 2025 CO2 targets - source By Gilles Guillaume PARIS, Oct 14 (Reuters) - Renault CEO Luca de Meo's bet on a low-cost gearbox technology is allowing the French carmaker to gain ground in Europe's fast-growing hybrid car market, giving it some breathing space a
A
P
R
T
V
V
Reuters - 2 mesi fa

Agilent Technologies Inc Files For Two-Part Senior Notes Offering Size Not Disclosed - SEC Filing

BRIEF-Agilent Technologies Inc Files For Two-Part Senior Notes Offering Size Not Disclosed - SEC Filing Agilent Technologies Inc A.N : AGILENT TECHNOLOGIES INC FILES FOR TWO-PART SENIOR NOTES OFFERING; SIZE NOT DISCLOSED - SEC FILING Source text for Eikon: [ID:n0001193125-24-212662] Further company coverage: A.N
A
Reuters - 3 mesi fa

U.S. Advance Auto Parts, Chewy, Workday

U.S. RESEARCH ROUNDUP-Advance Auto Parts, Chewy, Workday Aug 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Advance Auto Parts, Chewy and Workday, on Friday. HIGHLIGHTS * Advance Auto Parts Inc AAP.N : JP Morgan cuts target price to $43 from $55 * Chewy CHWY.N : Piper Sandler raises to overweight from neutral * Intuit Inc INTU.O : Jefferies raises target price to $790 from $770 * Williams-Sonoma Inc WSM.N : TD Co
A
A
A
B
I
J
N
N
R
R
H
A
Reuters - 3 mesi fa

U.S. STOCKS NetEase, Wolfspeed, B. Riley

BUZZ-U.S. STOCKS ON THE MOVE-NetEase, Wolfspeed, B. Riley Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes fell in volatile trading on Thursday, as rising Treasury yields pressured stocks ahead of Federal Reserve Chair Jerome Powell's speech at Jackson Hole that could offer clues on the possibility of a rate cut next month.
A
B
N
S
U
U
U
E
S
A
Reuters - 3 mesi fa

U.S. STOCKS Evogene, Stryker, Opera

BUZZ-U.S. STOCKS ON THE MOVE-Evogene, Stryker, Opera Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes fell in volatile trading on Thursday, as rising Treasury yields pressured stocks ahead of Federal Reserve Chair Jerome Powell's speech at Jackson Hole that could offer clues on the possibility of a rate cut next month.
A
B
B
I
N
U
U
U
E
S
A
Reuters - 3 mesi fa

Agilent Technologies rises on Q3 results beat

BUZZ-Agilent Technologies rises on Q3 results beat ** Shares of medical equipment maker Agilent Technologies A.N rise 3.6% to $145.03 after Q3 results ** Company reports Q3 revenue of $1.58 bln; above Wall Street expectations of $1.56 bln - LSEG data ** Quarterly adj EPS of $1.32 beat market estimate of $1.26 ** Co forecasts Q4 revenue between $1.6
A
Reuters - 3 mesi fa

U.S. Aadi Bioscience, Target, Visteon

U.S. RESEARCH ROUNDUP-Aadi Bioscience, Target, Visteon Aug 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aadi Bioscience, Target and Visteon, on Thursday. HIGHLIGHTS * Aadi Bioscience Inc AADI.O : Jefferies cuts to hold from buy * Assurant Inc AIZ.N : Piper Sandler cuts to neutral from overweight * Estée Lauder EL.N : Piper Sandler raises to overweight from neutral * Target Corp TGT.N : Jefferies raises target
A
A
H
S
T
T
U
A
P
U
D
E
A
Reuters - 3 mesi fa

Agilent Technologies Inc reports results for the quarter ended in July - Earnings Summary

Agilent Technologies Inc reports results for the quarter ended in July - Earnings Summary Agilent Technologies Inc A.N reported quarterly adjusted earnings of $1.32​​ per share for the quarter ended in July, lower than the same quarter last year, when the company reported EPS of $1.43. The mean expectation of seventeen analysts for the quarter was for earnings of $1.26 per share.
A
Reuters - 3 mesi fa

Agilent beats quarterly results on strong demand from biotech clients

Agilent beats quarterly results on strong demand from biotech clients Aug 21 (Reuters) - Agilent Technologies A.N on Wednesday beat Wall Street estimates for third-quarter profit and revenue, banking on strong demand for its medical tools and equipment used in clinical studies. "While market conditions continued to be challenged during the quarter, we saw steady signs of improvement as anticipated", said CEO Padraig McDonnell.
A
T
Reuters - 3 mesi fa

Agilent Q3 Revenue USD 1,578 Million Vs. IBES Estimate USD 1,558 Million

BRIEF-Agilent Q3 Revenue USD 1,578 Million Vs. IBES Estimate USD 1,558 Million Aug 21 (Reuters) - Agilent Q3 income from operations USD 333 million. Q3 net income USD 282 million Q3 pretax profit USD 343 million vs. IBES estimate USD 428.4 million Q3 EPS USD 0.97 Q3 adjusted net income USD 385 million vs. IBES estimate USD 371 million Q3 adjusted EPS USD 1.32 vs.
A
Reuters - 3 mesi fa

Agilent Technologies Inc <A.N> expected to post earnings of $1.26 a share - Earnings Preview

Agilent Technologies Inc expected to post earnings of $1.26 a share - Earnings Preview Agilent Technologies Inc A.N , A is expected to show a fall in quarterly revenue when it reports results on August 21 for the period ending January 1 0001 The Santa Clara California-based company is expected to report a 6.8% decrease in revenue to $1.558 billion from $1.67 billion a year ago, according to the mean estimate from 14 analysts, based on LSEG data.The company's guidance on May 29 2024, for the peri
A
Reuters - 3 mesi fa

U.S. earnings week ahead

DIARY-U.S. earnings week ahead Aug 16 (Reuters) - Diary of U.S. (.SPX) corporate earnings for the week ahead. ** Please Note - All times given are in U.S. EDT unless otherwise stated ** U.S. EARNINGS Start Date Start Time RIC Company Name Event Name 19-Aug-2024 AMC PANW.O Palo Alto Networks Inc Q4 2024 Palo Alto Networks Inc Earnings Release 19-Aug-2024 BMO EL Estee Lauder Companies Inc Q4 2024 Estee Lauder Companies Inc Earnings Release 20-Aug-2024 AMC KEYS Keysight Technologies Inc Q3 2024 Key
A
I
A
R
U
E
K

Condizioni

Asset popolari

Disclaimer: le entità di XM Group forniscono servizi di sola esecuzione e accesso al nostro servizio di trading online, che permette all'individuo di visualizzare e/o utilizzare i contenuti disponibili sul sito o attraverso di esso; non ha il proposito di modificare o espandere le proprie funzioni, né le modifica o espande. L'accesso e l'utilizzo sono sempre soggetti a: (i) Termini e condizioni; (ii) Avvertenza sui rischi e (iii) Disclaimer completo. Tali contenuti sono perciò forniti a scopo puramente informativo. Nello specifico, ti preghiamo di considerare che i contenuti del nostro servizio di trading online non rappresentano un sollecito né un'offerta ad operare sui mercati finanziari. Il trading su qualsiasi mercato finanziario comporta un notevole livello di rischio per il tuo capitale.

Tutto il materiale pubblicato sul nostro servizio di trading online è unicamente a scopo educativo e informativo, e non contiene (e non dovrebbe essere considerato come contenente) consigli e raccomandazioni di carattere finanziario, di trading o fiscale, né informazioni riguardanti i nostri prezzi di trading, offerte o solleciti riguardanti transazioni che possano coinvolgere strumenti finanziari, oppure promozioni finanziarie da te non richieste.

Tutti i contenuti di terze parti, oltre ai contenuti offerti da XM, siano essi opinioni, news, ricerca, analisi, prezzi, altre informazioni o link a siti di terzi presenti su questo sito, sono forniti "così com'è", e vanno considerati come commenti generali sui mercati; per questo motivo, non possono essere visti come consigli di investimento. Dato che tutti i contenuti sono intesi come ricerche di investimento, devi considerare e accettare che non sono stati preparati né creati seguendo i requisiti normativi pensati per promuovere l'indipendenza delle ricerche di investimento; per questo motivo, questi contenuti devono essere considerati come comunicazioni di marketing in base alle leggi e normative vigenti. Assicurati di avere letto e compreso pienamente la nostra Notifica sulla ricerca di investimento non indipendente e la nostra Informativa sul rischio riguardante le informazioni sopra citate; tali documenti sono consultabili qui.

Avvertenza sul rischio: Il tuo capitale è a rischio. I prodotti con leva finanziaria possono non essere adatti a tutti. Ti chiediamo di consultare attentamente la nostra Informativa sul rischio.